Robots for Cell Therapy manufacturing

ROBOTS manufacturing gene modified cell therapies to achieve industrial scale.

Key technology features

A unique, modular approach, to Cell Therapy automation that reduces manufacturing bottlenecks and minimizes human contamination.

Multiply Labs' robotic systems for cell therapy manufacturing are being developed in a Consortium with Cytiva, Thermo Fisher, Charles River Laboratories and UCSF.

To learn more, and to request a spot in our commercial deployment program, contact us.

Compatibility

Compatible with the market-leading GMP instruments

Xuri Bioreactor

Heracell VIOS

Rotea

Cytokine Syringes

VHP Sterilization

CytoSinct 1000

G-Rex Bioreactor

Each robotic module contains a single instrument; multiple modules are used together to automate a process

Flexibility

Any process can be implemented by selecting the corresponding combination of modules

Adaptable

It's easy to remove, add and swap modules

Parallelism (high-throughput)

A fully automated system where “fast” modules feed multiple parallel bioreactor modules

LINK

Want to learn more? Reach out!

Marae Hartwell

Recent News

Collaboration with Stanford GMP Facility

9 May 2024 News

Collaboration with Stanford GMP Facility We’re excited to share that we are establishing a collaboration with Stanford GMP Facility: Laboratory for Cell and Gene Medicine(LCGM) to deploy our robotic...

Read More

Automating the cell isolation with GenScript

9 May 2024 News

Automating the cell isolation with GenScript We’re excited to announce that we’ve partnered with GenScript to automate the cell isolation and enrichment phase of cell therapy manufacturing! Cell...

Read More

New partnership with Wilson Wolf Manufacturing, LLC

9 May 2024 News

New partnership with Wilson Wolf Manufacturing, LLC We’ve teamed up with Wilson Wolf Manufacturing, LLC to automate their G-Rex® bioreactors! This partnership is driven by our mutual goal to simplify...

Read More

Newsletter

Subscribe & get Company news.